Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
N/A
-525,628 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
N/A
-67,637 Reduced 11.4%
525,628 $2.58 Million
Q2 2021

Aug 11, 2021

BUY
N/A
285,565 Added 92.81%
593,265 $3.13 Million
Q1 2021

May 11, 2021

BUY
N/A
60,422 Added 24.43%
307,700 $1.48 Million
Q4 2020

Feb 11, 2021

BUY
N/A
22,736 Added 10.13%
247,278 $1.07 Million
Q3 2020

Nov 09, 2020

BUY
N/A
102,283 Added 83.66%
224,542 $925,000
Q2 2020

Aug 12, 2020

BUY
N/A
104,076 Added 572.38%
122,259 $313,000
Q1 2020

May 11, 2020

BUY
N/A
18,183 New
18,183 $53,000

About Adamas Pharmaceuticals, Inc.


  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.